183 related articles for article (PubMed ID: 20128690)
21. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
Zeng X; Tamai K; Doble B; Li S; Huang H; Habas R; Okamura H; Woodgett J; He X
Nature; 2005 Dec; 438(7069):873-7. PubMed ID: 16341017
[TBL] [Abstract][Full Text] [Related]
22. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
23. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
[TBL] [Abstract][Full Text] [Related]
24. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling.
Loke J; Pearlman A; Radi O; Zuffardi O; Giussani U; Pallotta R; Camerino G; Ostrer H
Hum Mol Genet; 2014 Feb; 23(4):1073-83. PubMed ID: 24135036
[TBL] [Abstract][Full Text] [Related]
25. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
26. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
27. CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
Park S; Lee MS; Gwak J; Choi TI; Lee Y; Ju BG; Kim CH; Oh S
Cell Death Dis; 2018 Oct; 9(10):1023. PubMed ID: 30283086
[TBL] [Abstract][Full Text] [Related]
28. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
29. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
30. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
31. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
33. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.
Mosimann C; Hausmann G; Basler K
Cell; 2006 Apr; 125(2):327-41. PubMed ID: 16630820
[TBL] [Abstract][Full Text] [Related]
34. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.
Biechele TL; Kulikauskas RM; Toroni RA; Lucero OM; Swift RD; James RG; Robin NC; Dawson DW; Moon RT; Chien AJ
Sci Signal; 2012 Jan; 5(206):ra3. PubMed ID: 22234612
[TBL] [Abstract][Full Text] [Related]
35. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
36. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
Zhang Y; Neo SY; Wang X; Han J; Lin SC
J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
[TBL] [Abstract][Full Text] [Related]
37. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
Valenta T; Lukas J; Korinek V
Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
[TBL] [Abstract][Full Text] [Related]
38. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
[TBL] [Abstract][Full Text] [Related]
40. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.
Notani D; Gottimukkala KP; Jayani RS; Limaye AS; Damle MV; Mehta S; Purbey PK; Joseph J; Galande S
PLoS Biol; 2010 Jan; 8(1):e1000296. PubMed ID: 20126258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]